| ORGN | Wednesday, 31 August 2005 | ||
2:30 PM-5:00 PM Washington DC Convention Center -- Ballroom C, Oral | |||
Technical Achievements in Organic Chemistry Awards | |||
| Organizer: | Robert A. Volkmann | ||
| Presiding: | Donna Huryn | ||
| 2:30 PM | 527 | Process development of AAE421: A somatostatin sst1 receptor antagonist Yansong J Lu, Bin Hu, Mahavir Prashad, Oljan Repič, Thomas J. Blacklock | |
| 3:00 PM | 528 | Process development of the hNK-1 receptor antagonist Aprepitant: From preclinical supplies to product launch Joseph F Payack, Karel M. J. Brands, Dongwei Cai, Ian F. Cottrell, Paul N. Devine, Karl Hansen, David L. Hughes, Mark A. Huffman, James McNamara, Todd D. Nelson, Philip J. Pye, Jonathan D. Rosen | |
| 3:30 PM | 529 | Development of a manufacturing process for Δ 9(11)-canrenone Mark J. Pozzo | |
| 4:00 PM | 530 | Application of crystallization technologies to process development and manufacture of active pharmaceutical ingredients Peter R. Rose | |
| 4:30 PM | 531 | I: Synthesis and structure activity relationship of novel SSRI/5HT1A antagonists. II: Design and synthesis of 1,3-dihydrobenzimidazole-2-ones, 1,3-dihydobenzimidazole-2-thiones and 1,4-dihydroquinoxalines as dopamine D2 agonists Uresh Shah, Deborah A. Evrard, Gary Stack, Richard Mewshaw, Dahui Zhou, James Nelson | |
Previous Session -- Technical Achievements in Organic Chemistry Awards
Symposium Grid -- Division of Organic Chemistry -- Session Listing
The 230th ACS National Meeting, in Washington, DC, Aug 28-Sept 1, 2005